Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Conversations with Panmure Gordon

In the latest episode of Conversations with Panmure Gordon, Daniel Koller, Head of Investment team at BB Biotech joins Julie Simmonds, Healthcare Analyst to explore the current market opportunities in the biotech sector and areas of focus where the company sees the most exciting potential value and growth prospects.
18.04.2024 - Daniel Koller

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993